Evidence map›Paper›PMID 39633183›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2025

First-in-human administration of [

Alin Chirindel, Guillaume P Nicolas, Frida Westerbergh, Lisa McDougall, David E Schmid, Susanne Geistlich, Viviane J Tschan, Sarah D Busslinger, Angelique Fokkema, Nicola Aceto and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Dosimetry-Driven Personalization of Radiopharmaceutical Therapies: Evidence and Opportunities.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Review
  2. Tolerability of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  3. Emerging Theranostic Radiometals (Pharmaceuticals (Basel, Switzerland) · 2026
    Review
  4. Review
  5. Safety and efficacy of [European journal of nuclear medicine and molecular imaging · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Preclinical investigation of [European journal of nuclear medicine and molecular imaging · 2025
    Article
  10. Pilot experience of [Theranostics · 2025
    Observational
  11. Frontiers in oncology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Alin ChirindelDivision of Nuclear Medicine, University Hospital Basel, Petersgraben 4, Basel, CH-4031, Switzerland.
Guillaume P NicolasDivision of Nuclear Medicine, University Hospital Basel, Petersgraben 4, Basel, CH-4031, Switzerland.
Frida WesterberghDepartment of Medical Radiation Sciences, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Lisa McDougallDivision of Nuclear Medicine, University Hospital Basel, Petersgraben 4, Basel, CH-4031, Switzerland.
David E SchmidPSI Center for Life Sciences, Villigen-PSI, Canton of Aargau, Switzerland.
Susanne GeistlichPSI Center for Life Sciences, Villigen-PSI, Canton of Aargau, Switzerland.
Viviane J TschanPSI Center for Life Sciences, Villigen-PSI, Canton of Aargau, Switzerland.
Sarah D BusslingerPSI Center for Life Sciences, Villigen-PSI, Canton of Aargau, Switzerland.
Angelique FokkemaDepartment of Biology, Institute for Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.
Nicola AcetoDepartment of Biology, Institute for Molecular Health Sciences, ETH Zurich, Zurich, Switzerland.
Peter BernhardtDepartment of Medical Radiation Sciences, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Nicholas P van der MeulenPSI Center for Life Sciences, Villigen-PSI, Canton of Aargau, Switzerland.
Cristina MüllerPSI Center for Life Sciences, Villigen-PSI, Canton of Aargau, Switzerland.
Damian WildDivision of Nuclear Medicine, University Hospital Basel, Petersgraben 4, Basel, CH-4031, Switzerland. damian.wild@usb.ch.ORCID http://orcid.org/0000-0002-8135-5350
Roger SchibliPSI Center for Life Sciences, Villigen-PSI, Canton of Aargau, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39633183
PMCPMC11928360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.